Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid a... by Frank Vandenabeele, Johan Joly, Patrick Verschueren, Veerle Somers, Patrick Vandormael, Sukayna Fadlallah, Pieter Ruytinx, Astrid Pues, Ellen Sleurs, Jori Liesenborgs, Anouk Agten, Judith Fraussen

Get full text